Healthcare Industry News:  GSK 

Biopharmaceuticals Personnel

 News Release - December 19, 2006

Adrian Rawcliffe to Lead GlaxoSmithKline's Worldwide Business Development

LONDON and PHILADELPHIA, Dec. 19 (HSMN NewsFeed) -- GlaxoSmithKline (NYSE: GSK ) announces that Adrian Rawcliffe has been appointed Senior Vice President, Worldwide Business Development, Research & Development, effective immediately.

Rawcliffe had most recently served as Managing Partner and President, SR One Ltd., GSK's venture-capital business. In his new role, he succeeds Moncef Slaoui, now chairman, R&D.

Rawcliffe will report to Dr. Slaoui and have global responsibility for all business-development activities including in-licensing, collaborations, and alliance management.

Dr. Slaoui commented, "Ad brings to our business-development function a proven capacity to work with our business partners, current and potential, in a way that maximizes value for all parties. He will be leading a function that is embedded in our R&D organization and committed to making our R&D strengths an advantage for our partners as well as for ourselves."

At GSK, Rawcliffe has led teams executing a broad range of strategic transactions, including acquisitions, in-licenses, technology alliances, out- licenses, divestitures, joint ventures, and the formation of consortia.

He was appointed to his position at SR One in 2005. Previously, he served as Vice President, Genetics and Discovery Deal Structuring, concentrating on collaborations in early-stage drug development, and Vice President, Transactions and Ventures, leading a US-based transactions team whose activities encompassed both in-licensing and out-licensing.

Rawcliffe holds a BSc degree in Natural Sciences from the University of Durham, UK. He joined GSK in 1997 from Coopers and Lybrand, where he was a Chartered Accountant involved in a range of business-advisory activities.

His successor at SR One will be appointed in due course.

GlaxoSmithKline -- one of the world's leading research-based pharmaceutical and healthcare companies -- is committed to improving the quality of human life by enabling people to do more, feel better, and live longer.

Source: GlaxoSmithKline

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.